Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01OND
|
|||
Former ID |
DNC011053
|
|||
Drug Name |
3-(dimethylamino)phenyl phenylcarbamate
|
|||
Synonyms |
3-(dimethylamino)phenyl phenylcarbamate; CHEMBL1171854; AC1L2FAU; AC1Q61FO; YNGSTYODGGYXSA-UHFFFAOYSA-N; BDBM50321912; AKOS029953756; [3-(dimethylamino)phenyl] N-phenylcarbamate; phenol, 3-(dimethylamino)-, phenylcarbamate (ester)
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H16N2O2
|
|||
Canonical SMILES |
CN(C)C1=CC(=CC=C1)OC(=O)NC2=CC=CC=C2
|
|||
InChI |
1S/C15H16N2O2/c1-17(2)13-9-6-10-14(11-13)19-15(18)16-12-7-4-3-5-8-12/h3-11H,1-2H3,(H,16,18)
|
|||
InChIKey |
YNGSTYODGGYXSA-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Acetylcholinesterase (AChE) | Target Info | Inhibitor | [1] |
Cholinesterase (BCHE) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Glycerophospholipid metabolism | |||
Cholinergic synapse | ||||
Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
Nicotinic acetylcholine receptor signaling pathway | ||||
Pathwhiz Pathway | Phospholipid Biosynthesis | |||
Pathway Interaction Database | ATF-2 transcription factor network | |||
WikiPathways | Irinotecan Pathway | |||
Monoamine Transport | ||||
Biogenic Amine Synthesis | ||||
Acetylcholine Synthesis | ||||
Integrated Pancreatic Cancer Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. Bioorg Med Chem. 2010 Jul 1;18(13):4687-93. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.